Campath 30mg Injection

Alemtuzumab (30mg) Primary uses of : Blood cancer (Chronic lymphocytic leukemia), Multiple sclerosis (MS)
Manufacturer: Zydus Cadila
*
₹ 86.25 incl tax
Expert advice for Campath Injection Alemtuzumab may sometimes cause life-threatening reactions like chest pain, breathlessness, slow or irregular heartbeat and therefore you will be closely monitored during and 2 hours after the infusion. Seek immediate medication attention if you notice unusual bruising or bleeding, blood in urine, swelling of legs or feet, or if you cough up blood. Avoid activities that may increase your risk of bleeding or injury. Take necessary care to prevent bleeding while shaving or brushing your teeth. Serious infections may occur during alemtuzumab treatment. Inform doctor immediately if you develop fever, chills, cough, mouth sores, or trouble breathing. Avoid contact with people who have infections. Do not receive live vaccines if you have recently received alemtuzumab.
Composition Alemtuzumab (30mg)
Side Effect Common Side Effects of Campath are Rash, Headache, Insomnia (difficulty in sleeping), Nausea, Upper respiratory tract infection, Decreased white blood cell count, Fatigue, Fever, Itching, Flushing (sense of warmth in the face, ears, neck and trunk), Urticaria, Decreased white blood cell count (lymphocytes).
How to works How Campath Injection works Campath 30 mg Injection is a monoclonal antibody. It flags the cancer cells for destruction by the body's immune system. It also modulates the immune system to limit its attacks on the nervous system.